One of the most modern scientific practices related to genetics and eugenics is genetic engineering. Eugenics refers to "well-born," whereby the method involves genetic efforts made to produce viable offspring. After World War II, the practice lost credibility due to the extreme atrocities practiced by Hitler and the Nazi's. Despite the halting of eugenic practices, the act of sterilization still went on. New methods, however, emerged after some years that were associated with medical technology and the idea of genetic testing and treatment.
Human genetic engineering formerly referred to as eugenics nowadays focusses on transforming or removing genes to avoid diseases, cure infections, and develop a person's body in the perfect way possible. The possible health benefits that can be achieved through the practice of human gene therapy have, however, become less popular because most devastating diseases are curable through pharmaceutical means ( Roberts et al., 2014 ). Besides, modern genetic engineering is associated with additional expenses and repercussions. For instance, due to the significant technological advancements in genetic testing and treatment, people now can occasionally delete undesirable features in their progenies ( Knott & Doudna, 2018) . Another related practice is that parents, through genetic engineering, allows parents to determine abnormalities in their young ones in utero and hence can terminate their pregnancies before birth.
Delegate your assignment to our experts and they will do the rest.
From a personal perspective, such liberties that involve the exclusion of certain traits from an infant's genetic composition is controversial and non-justifiable. It is every offspring's right to be born regardless of any "negative" traits and that natural existence should not be altered. Generally, there is still much to be done regarding eugenics and genetics when it comes to genetic testing and treatment, as it may have present and future implications on the human race.
References
Knott, G. J., & Doudna, J. A. (2018). CRISPR-Cas guides the future of genetic engineering. Science , 361 (6405), 866-869.
Roberts, J. D., Wells, G. A., Le May, M. R., Labinaz, M., Glover, C., Froeschl, M., ... & Druce, I. (2014). Point-of-care genetic testing for personalization of antiplatelet treatment (RAPID GENE): a prospective, randomized, proof-of-concept trial. The Lancet , 379 (9827), 1705-1711.
